Aurinia Pharmaceuticals (AUPH) Selling, General & Administrative (2020 - 2026)

Aurinia Pharmaceuticals (AUPH) Selling, General & Administrative (2020 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) SG&A (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -10.08 Mn
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 555.10 Mn
4 NuCana 279.75 Bn 279.75 Bn - -1.47 Mn
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 493.70 Mn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 647.70 Mn
7 Belite Bio 62.51 Bn 62.51 Bn - 17.02 Mn
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 1.13 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn - 101.25 Mn
10 Aurinia Pharmaceuticals 2.02 Bn 1.64 Bn 71.20 Mn 22.03 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 22.03 Mn
Dec 31, 2025 29.26 Mn
Sep 30, 2025 26.18 Mn
Jun 30, 2025 26.02 Mn
Mar 31, 2025 20.34 Mn
Dec 31, 2024 37.03 Mn
Sep 30, 2024 42.37 Mn
Jun 30, 2024 44.93 Mn
Mar 31, 2024 47.70 Mn
Dec 31, 2023 50.07 Mn
Sep 30, 2023 47.76 Mn
Jun 30, 2023 47.08 Mn
Mar 31, 2023 50.12 Mn
Dec 31, 2022 47.47 Mn
Sep 30, 2022 52.17 Mn
Jun 30, 2022 51.53 Mn
Mar 31, 2022 45.20 Mn
Dec 31, 2021 44.76 Mn
Sep 30, 2021 44.65 Mn
Jun 30, 2021 44.32 Mn